Evidence-Based Medicine

Research Appraisals

Evidence-based critical appraisals of the latest medical research, systematically evaluated using Oxford CEBM methodology.

Showing 2 appraisals

Randomised Controlled TrialEvidence: Moderate
65CEBM

Journal of chemical information and modeling

HELMify: A Hybrid Rule- and LLM-Based Generator of Peptide Monomer HELM Names

HELM is a hierarchical notation system for biopolymers that is an increasingly popular choice for representing peptides. In this system, each monomer name must uniquely identify a single monomer, and until now, chemists have named peptide monomers by hand using a limited set of rules. As the chemical space of monomers is practically unlimited, this naming process is too time-consuming to be done by chemists and is prone to inconsistency. To address this bottleneck, we developed a public benchmark data set for this task and two complementary automated naming approaches for HELM name generation: a zone-based namer, which relies on hand-curated dictionaries of substructures, and a generative AI namer, which relies on a pretrained Large Language Model (LLM) with chemistry world knowledge. We evaluated both approaches on a set of publicly disclosed alpha amino acids. For a time-split test set, the zone-based namer produced usable names for 84% of cases: 54% matched the human-generated name exactly, and an additional 30% did not match but were interpretable as the correct structure. The LLM-based namer produced usable names for 42% of cases: 33% of the names matched the human-generated name exactly, and an additional 9% were nonidentical but still interpretable as the correct structure. In another 49% of LLM-generated cases, the outputs were considered close matches, and while not directly usable, they can still inform the generation of correct names. The zone-based namer is deterministic, fast, and independent of any previous names, explicitly handling zone order and chirality. The LLM-based namer can generalize from human-named examples to propose names for novel chemical groups, helping fill library gaps. Together, the approaches offer complementary coverage: rules-based precision and speed paired with data-driven flexibility for novel moieties. Combining the strengths of both approaches paves the way for an automated peptide monomer naming process that can accelerate research by (i) helping the community establish standardized guidelines for the rapidly expanding noncanonical amino acid (ncAA) space, (ii) streamlining integration with synthesis planning, inventory management, and analysis pipelines, (iii) enabling more consistent annotation in ELNs, databases, and publications, and (iv) facilitating cross-lab replication and data exchange. Together, these advances can expedite method development, reduce ambiguity in collaboration, and ultimately support the discovery of novel peptides with improved drug-like properties.

29 July 2026

Read appraisal →
Systematic ReviewEvidence: Weak
50CEBM

Analytical methods : advancing methods and applications

Spatial metabolomics in medicinal plant research: current advances, technical challenges, and future perspectives

Secondary metabolites derived from medicinal plants represent a critical resource for drug discovery and play an indispensable role in the prevention and treatment of major human diseases. Spatial metabolomics has emerged as a transformative approach that overcomes the inherent limitations of traditional metabolomics, particularly tissue homogenisation, by enabling precise, in situ profiling of the spatial heterogeneity and dynamic accumulation of key bioactive compounds. When integrated with complementary technologies such as spatial multi-omics (SMO), single-cell analysis, and artificial intelligence (AI)-assisted imaging, this paradigm provides a powerful framework for deciphering the spatiotemporal regulatory networks that govern secondary metabolite biosynthesis. This review systematically compares conventional and spatial metabolomics, synthesises recent advances in medicinal plant research, critically evaluates current technical challenges and optimisation strategies, and outlines future directions enabled by multi-omics integration and intelligent computational analytics. Collectively, these insights aim to establish a theoretical foundation for the in-depth investigation of medicinal plants and to support their translational application and industrial advancement.

19 July 2026

Read appraisal →